Skip to main content

Security report for apotex.com

Apotex Inc. · Healthcare · Canada

Low risk. 1 critical or high finding in SSL/TLS.

Security score

79/100

Risk levelLow

0–100, higher is better. How it is calculated

Apotex Inc. is a well-established Canadian-based global pharmaceutical company specializing in generics, biosimilars, innovative specialty medicines, and consumer health products. The company positions itself as a leader in accessible, high-quality healthcare solutions with a significant global footprint serving approximately 70 countries and a large manufacturing capacity. The website reflects a mature enterprise with comprehensive content, clear navigation, and consistent branding aligned with its corporate identity. Technically, the website is built on the Sitefinity CMS platform with Bootstrap 5 for responsive design, leveraging modern JavaScript and Google Tag Manager for analytics. The site demonstrates good performance, mobile optimization, and accessibility standards. Privacy and cookie policies are present with a consent mechanism, indicating compliance with GDPR and related regulations. From a security perspective, the site uses HTTPS and has domain transfer protections in place. However, it lacks DNSSEC and some advanced security headers, and no explicit vulnerability disclosure or incident response contacts are provided. No critical vulnerabilities or suspicious indicators were detected. The WHOIS data confirms domain legitimacy with a long registration history consistent with the company's profile. Overall, Apotex.com is a professional, secure, and compliant corporate website with strong business credibility and digital maturity. Strategic improvements in DNS security and explicit security communication could further enhance trust and resilience.

Scanned

NIS2 and GDPR posture

GDPR outside view
83/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

1 finding rated critical or high. Fix these first.

  1. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching apotex.com

This scan found 20 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
77
Security headers
70
Email security
70
DNS health
75
Network security
100
GDPR outside view
83
Average
79

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Apotex operates in the pharmaceutical healthcare sector with a focus on generics and biosimilars, targeting healthcare providers, patients, and partners worldwide. The company leverages a business model centered on manufacturing and distributing affordable medicines globally. Its competitive advantages include a large manufacturing capacity, regulatory approvals (e.g., Health Canada), and a diversified product portfolio. The website content and news releases indicate ongoing product launches and sustainability initiatives, signaling growth and innovation. The company maintains a global partnership ecosystem but does not publicly list subsidiaries or parent companies on the site. The digital presence supports brand trust and market positioning as a leading global health company.

Security posture

The website demonstrates a solid security posture with HTTPS enforced and domain transfer protections. Cookie consent and privacy policies are implemented, supporting regulatory compliance. However, the absence of DNSSEC and advanced HTTP security headers represents an area for improvement. No direct incident response or security contact information is provided, which could hinder rapid response to security events. The use of Google Tag Manager and Analytics is managed with user consent, aligning with privacy best practices. No vulnerabilities or exposed sensitive data were detected in the content. Overall, the security maturity is good but could be enhanced with additional controls and transparency.

Recommendations

  1. Enable DNSSEC on the domain to protect against DNS spoofing and improve overall DNS security.
  2. Implement additional HTTP security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
  3. Publish a security.txt file or a dedicated vulnerability disclosure page with clear contact information for security issues.
  4. Provide explicit incident response contact channels (e.g., security@ or abuse@ email addresses) to improve transparency and readiness.
  5. Regularly review and update third-party scripts and tracking tools to minimize privacy risks and ensure compliance.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Apotex Inc.
Description
Delivering accessible, high-quality generics, innovative branded pharmaceuticals, biosimilars and consumer health products to keep lives in motion.
Key services
Generics, Biosimilars, Innovative & specialty medicines, Consumer health products
Content quality
excellent
Branding
consistent

Technology

Stack
JavaScript, Telerik Sitefinity, Bootstrap 5, Google Tag Manager
Frameworks
Bootstrap 5, Sitefinity CMS
Platforms
Sitefinity CMS
Performance
fast
Mobile
excellent
Accessibility
good
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • clientTransferProhibited domain status
  • Cookie consent mechanism implemented

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Google Analytics (via Google Tag Manager)
Transparency
basic

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Content is comprehensive and relevant to pharmaceutical industry.
  3. No signs of malicious or suspicious activity.
  4. Good compliance with privacy and cookie policies.
  5. No direct contact emails or phone numbers found on main page; contact via form only.
  6. No explicit security.txt or vulnerability disclosure found.
  7. Google Analytics used with consent mechanism in place.
Technical notes

Notes

The website is built on a modern technology stack including Sitefinity CMS and Bootstrap 5, ensuring responsive and accessible design. JavaScript is used for interactive elements and analytics integration via Google Tag Manager. The site loads efficiently with optimized images and structured navigation. Meta tags and canonical URLs support SEO best practices. The absence of DNSSEC and some security headers indicates minor technical debt in security hardening. Overall, the infrastructure supports a robust and scalable digital presence suitable for an enterprise pharmaceutical company.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with apotex.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review apotex.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.